GLP-1 Agonists Linked to 20-30% Lean Mass Loss in Weight Reduction, Potentially Compromising Cancer Treatment Tolerance
GLP-1 receptor agonists like semaglutide and tirzepatide cause weight loss that's 20-30% lean muscle mass, not just fat tissue. This muscle loss becomes…